Drug:
Reaction: HAEMORRHAGE
20250101 - 20251231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 25081559 |
US |
9 | 1 |
Haemorrhage, Pain, Discomfort, |
||||
INSULIN LISPRO, |
||||
| 502 | 25081561 |
US |
74 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 503 | 25081563 |
US |
71 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 504 | 25081573 |
US |
68 | 2 |
Haemorrhage, Injection site bruising, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 505 | 25081713 |
US |
32 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 506 | 25085969 |
31 | 1 | |
Fall, Cerebral haemorrhage, Arterial injury, Haemorrhage, Intraventricular haemorrhage, |
||||
WARFARIN, |
||||
| 507 | 25089233 |
61 | 2 | |
Colitis ischaemic, Haemorrhage, Abdominal pain upper, |
||||
TIRZEPATIDE, LISINOPRIL, ERGOCALCIFEROL, ESOMEPRAZOLE MAGNESIUM, |
||||
| 508 | 25080433 |
US |
76 | 2 |
Haemorrhage, Fatigue, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 509 | 25080542 |
US |
76 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 510 | 25080595 |
US |
69 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 511 | 25080658 |
US |
1 | |
Haemorrhage, |
||||
ADALIMUMAB-ADBM, |
||||
| 512 | 25080772 |
US |
75 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 513 | 25080831 |
US |
56 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 514 | 25080832 |
US |
11 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 515 | 25080852 |
US |
40 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 516 | 25080943 |
US |
2 | |
Haemorrhage, |
||||
OFATUMUMAB, |
||||
| 517 | 25081173 |
US |
56 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 518 | 25077451 |
US |
50 | 1 |
Dry skin, Haemorrhage, |
||||
LENALIDOMIDE, |
||||
| 519 | 25077519 |
US |
42 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 520 | 25077576 |
US |
77 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 521 | 25077634 |
US |
15 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 522 | 25077641 |
US |
20 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 523 | 25077745 |
US |
10 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 524 | 25077848 |
US |
13 | 1 |
Haemorrhage, Arthralgia, |
||||
EMICIZUMAB, |
||||
| 525 | 25077901 |
CA |
77 | 2 |
Aortic aneurysm, Haemorrhage, Cardiac disorder, Heart rate increased, Hypertension, Peripheral swelling, Pruritus, Pyrexia, Scratch, Swelling, Urticaria, Wound secretion, Therapeutic product effect incomplete, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, |
||||
| 526 | 25078919 |
US |
74 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 527 | 25079711 |
US |
62 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 528 | 25079770 |
US |
74 | |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 529 | 25079817 |
US |
33 | 2 |
Haemorrhage, Menstrual disorder, Treatment failure, |
||||
HUMAN IMMUNOGLOBULIN G, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, |
||||
| 530 | 25080097 |
JP |
3 | 2 |
Cystitis haemorrhagic, Sexually transmitted disease, Haemorrhage, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 531 | 25080171 |
JP |
46 | 2 |
Haemorrhage, |
||||
LENVATINIB, LENVATINIB, |
||||
| 532 | 25071924 |
US |
1 | |
Loss of consciousness, Head injury, Chest pain, Respiratory disorder, Haemorrhage, Blood pressure decreased, Body temperature decreased, Dyspnoea, Haemoptysis, Device leakage, Drug dose omission by device, |
||||
AMIKACIN, |
||||
| 533 | 25072015 |
US |
76 | 1 |
Oesophageal injury, Haemorrhage, |
||||
TOCILIZUMAB, |
||||
| 534 | 25072037 |
US |
20 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 535 | 25072088 |
US |
66 | 1 |
Haemorrhage, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 536 | 25072106 |
US |
10 | 1 |
Haemorrhage, Discomfort, Pain, |
||||
INSULIN LISPRO, |
||||
| 537 | 25072248 |
US |
70 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 538 | 25072253 |
US |
64 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 539 | 25072254 |
US |
70 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 540 | 25072260 |
US |
29 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 541 | 25072336 |
US |
31 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 542 | 25072338 |
US |
76 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 543 | 25072340 |
US |
36 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 544 | 25072409 |
US |
17 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 545 | 25072411 |
US |
78 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 546 | 25072412 |
US |
76 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 547 | 25072419 |
US |
82 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 548 | 25072420 |
US |
75 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 549 | 25072499 |
US |
73 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 550 | 25072500 |
US |
65 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 551 | 25072505 |
US |
32 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 552 | 25072603 |
US |
7 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 553 | 25072604 |
US |
66 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 554 | 25072900 |
US |
38 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 555 | 25073019 |
US |
78 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 556 | 25073025 |
US |
57 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 557 | 25073101 |
US |
55 | 2 |
Haemorrhage, Platelet count decreased, Dry skin, Hypersensitivity, Off label use, Product prescribing issue, Product dose omission issue, Nausea, Dizziness, |
||||
FOSTAMATINIB, FOSTAMATINIB, |
||||
| 558 | 25073135 |
US |
54 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 559 | 25073143 |
US |
82 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 560 | 25073144 |
US |
61 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 561 | 25073149 |
US |
12 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 562 | 25073406 |
US |
39 | |
Pain, Discomfort, Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 563 | 25073553 |
US |
62 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 564 | 25073565 |
US |
65 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 565 | 25073950 |
US |
65 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 566 | 25073956 |
US |
69 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 567 | 25074413 |
ES |
88 | 1 |
Renal dysplasia, Chromaturia, Dyspnoea, Disorientation, Haemorrhage, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, |
||||
| 568 | 25074453 |
US |
65 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 569 | 25074486 |
US |
2 | |
Crohn^s disease, Furuncle, Product dose omission issue, Inappropriate schedule of product administration, Haemorrhage, |
||||
VEDOLIZUMAB, |
||||
| 570 | 25074745 |
US |
66 | 2 |
Haemorrhage, Pain, Discomfort, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 571 | 25075031 |
CN |
65 | 2 |
Platelet count decreased, Diarrhoea, Epistaxis, Decreased appetite, Abdominal distension, Abdominal pain, C-reactive protein increased, Haemorrhage, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, PAZOPANIB, PAZOPANIB HYDROCHLORIDE, PAZOPANIB, PAZOPANIB HYDROCHLORIDE, |
||||
| 572 | 25075275 |
MX |
20 | 1 |
Haemorrhage, Cytokine release syndrome, Thrombocytopenia, Diffuse alveolar damage, Epistaxis, |
||||
BLINATUMOMAB, BLINATUMOMAB, |
||||
| 573 | 25075297 |
US |
62 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 574 | 25075536 |
US |
35 | 1 |
Haemorrhage, Product prescribing issue, |
||||
| 575 | 25075573 |
US |
8 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
| 576 | 25076052 |
US |
80 | 2 |
Skin fissures, Haemorrhage, Dry skin, |
||||
APIXABAN, |
||||
| 577 | 25076409 |
US |
72 | 2 |
Haemorrhage, Infusion site pruritus, Infusion site erythema, |
||||
| 578 | 25076458 |
US |
55 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 579 | 25076666 |
US |
71 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 580 | 25076700 |
US |
76 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 581 | 25076828 |
US |
61 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 582 | 25076829 |
US |
46 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 583 | 25078230 |
1 | ||
Toe amputation, Skin ulcer, Haemorrhage, |
||||
DASATINIB, |
||||
| 584 | 25078293 |
2 | ||
Needle issue, Device leakage, Limb injury, Haemorrhage, Product contamination physical, |
||||
BENRALIZUMAB, |
||||
| 585 | 25066017 |
US |
79 | 2 |
Pain, Haemorrhage, Discomfort, |
||||
INSULIN LISPRO, |
||||
| 586 | 25066068 |
US |
80 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 587 | 25066120 |
US |
6 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
| 588 | 25066288 |
US |
40 | 1 |
Fracture of penis, Haemorrhage, Erectile dysfunction, |
||||
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, |
||||
| 589 | 25066315 |
US |
42 | 2 |
Haemorrhage, Injection site discomfort, Injection site pain, |
||||
INSULIN LISPRO-AABC, |
||||
| 590 | 25066317 |
US |
66 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DETEMIR, |
||||
| 591 | 25066359 |
US |
26 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, EMICIZUMAB, |
||||
| 592 | 25066361 |
US |
1 | |
Fall, Haemorrhage, |
||||
EMICIZUMAB, |
||||
| 593 | 25066362 |
US |
54 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, EMICIZUMAB, |
||||
| 594 | 25066363 |
US |
10 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
| 595 | 25066385 |
US |
1 | |
Haemorrhage, Insurance issue, Product use issue, |
||||
| 596 | 25066631 |
US |
49 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 597 | 25066681 |
US |
||
Thrombocytopenia, Haemorrhage, |
||||
REVUMENIB, |
||||
| 598 | 25067027 |
US |
2 | |
Suspected transmission of an infectious agent via product, Eye infection bacterial, Hypersensitivity, Throat tightness, Sinusitis, Ear infection, Facial pain, Haemorrhage, Blood pressure increased, |
||||
AZELASTINE HYDROCHLORIDE, AZELASTINE, CEFDINIR, OFLOXACIN, OFLOXACIN OTIC, OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3%, OFLOXACIN OTIC SOLUTION, |
||||
| 599 | 25067300 |
JP |
2 | |
Haemorrhage, |
||||
TOCILIZUMAB, |
||||
| 600 | 25067509 |
US |
||
Hospitalisation, Gastrointestinal disorder, Hernia, Haemorrhage, Epigastric discomfort, Dry mouth, Feeding disorder, Ulcer, |
||||
BELIMUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28